Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study

Cancer

Volumn 123, Issue 7, 2017, Pages 1202-1211

  Mahale, Parag ^a,b   Torres, Harrys A ^c   Kramer, Jennifer R ^d   Hwang, Lu Yu ^b   Li, Ruosha ^b   Brown, Eric L ^b   Engels, Eric A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

and End Results (SEER) Medicare; cancers; cholangiocarcinoma; elderly; Epidemiology; hepatitis C virus; hepatocellular carcinoma; lymphoma; Surveillance

Indexed keywords

AGE; AGED; ALCOHOL ABUSE; ANUS CANCER; ARTICLE; BILE DUCT CARCINOMA; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DIFFUSE LARGE B CELL LYMPHOMA; DISEASE ASSOCIATION; EXTRAHEPATIC BILE DUCT; FEMALE; GENDER; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER CANCER; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MEDICARE; MERKEL CELL TUMOR; MYELODYSPLASTIC SYNDROME; NON MELANOMA SKIN CANCER; PANCREAS CANCER; PREVALENCE; PROSTATE CANCER; RACE; SENSITIVITY ANALYSIS; SKIN APPENDAGE DISEASE; SOCIAL STATUS; UNITED STATES; UTERUS CANCER; VERY ELDERLY; COMPLICATION; HEPACIVIRUS; NEOPLASMS; ODDS RATIO; REGISTER; RISK; SOCIOECONOMICS; VIROLOGY;

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; NEOPLASMS; ODDS RATIO; PREVALENCE; REGISTRIES; RISK; SEER PROGRAM; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 85015900851     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.30559     Document Type: Article

References (49)

1. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med. 2014;160:293-300.
2. Alter HJ, Seeff LB. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome. Semin Liver Dis. 2000;20:17-35.
3. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology. 2002;36:1439-1445.
4. Negro F, Forton D, Craxi A, Sulkowski MS, Feld JJ, Manns MP. Extrahepatic morbidity and mortality of chronic hepatitis C. Gastroenterology. 2015;149:1345-1360.
5. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Biological agents. Volume 100 B. A review of human carcinogens. IARC Monogr Eval Carcinog Risks Hum. 2012;100(pt B):1-441.
6. Su FH, Chang SN, Chen PC, et al. Positive association between hepatitis C infection and oral cavity cancer: a nationwide population-based cohort study in Taiwan [serial online]. PLoS One. 2012;7:e48109.
7. Mahale P, Sturgis EM, Tweardy DJ, Ariza-Heredia EJ, Torres HA. Association between hepatitis C virus and head and neck cancers. J Natl Cancer Inst. 2016;108. pii: djw035.
8. El-Serag HB, Engels EA, Landgren O, et al. Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: a population-based study of US veterans. Hepatology. 2009;49:116-123.
9. Huang J, Magnusson M, Torner A, Ye W, Duberg AS. Risk of pancreatic cancer among individuals with hepatitis C or hepatitis B virus infection: a nationwide study in Sweden. Br J Cancer. 2013;109:2917-2923.
10. Gordon SC, Moonka D, Brown KA, et al. Risk for renal cell carcinoma in chronic hepatitis C infection. Cancer Epidemiol Biomarkers Prev. 2010;19:1066-1073.
11. Carrozzo M, Quadri R, Latorre P, et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol. 2002;37:364-369.
12. Sansonno D, Lotesoriere C, Cornacchiulo V, et al. Hepatitis C virus infection involves CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. Blood. 1998;92:3328-3337.
13. Yan FM, Chen AS, Hao F, et al. Hepatitis C virus may infect extrahepatic tissues in patients with hepatitis C. World J Gastroenterol. 2000;6:805-811.
14. Allison RD, Tong X, Moorman AC, et al. Increased incidence of cancer and cancer-related mortality among persons with chronic hepatitis C infection, 2006-2010. J Hepatol. 2015;63:822-828.
15. Nyberg AH, Chung JW, Shi JM, et al. Increased cancer rates in patients with chronic hepatitis C: an analysis of the cancer registry in a large US health maintenance organization [abstract]. J Hepatol. 2015;62(suppl 2):S220.
16. Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep. 2012;61(RR-4):1-32.
17. National Cancer Institute. Surveillance, Epidemiology, and End Results Program. Available at: http://seer.cancer.gov. Accessed August 19, 2016.
18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(8 suppl): IV-3-IV-18.
19. Engels EA, Pfeiffer RM, Ricker W, Wheeler W, Parsons R, Warren JL. Use of Surveillance, Epidemiology, and End Results-Medicare data to conduct case-control studies of cancer among the US elderly. Am J Epidemiol. 2011;174:860-870.
20. Clegg LX, Reichman ME, Miller BA, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the Surveillance, Epidemiology, and End Results: National Longitudinal Mortality Study. Cancer Causes Control. 2009;20:417-435.
21. Omland LH, Osler M, Jepsen P, et al. Socioeconomic status in HCV infected patients—risk and prognosis. Clin Epidemiol. 2013;5:163-172.
22. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodological). 1995;57:289-300.
23. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health. 1998;88:15-19.
24. Anderson LA, Pfeiffer R, Warren JL, et al. Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev. 2008;17:3069-3075.
25. de Sanjose S, Benavente Y, Vajdic CM, et al. Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol. 2008;6:451-458.
26. Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS. 2014;28:2313-2318.
27. Ma X, Does M, Raza A, Mayne ST. Myelodysplastic syndromes: incidence and survival in the United States. Cancer. 2007;109:1536-1542.
28. Maruyama S, Koda M, Oi S, Murawaki Y. Successful treatment of myelodysplastic syndrome and chronic hepatitis C using combined peginterferon-alpha-2b and ribavirin therapy. Hepatol Res. 2014;44:1159-1164.
29. Li H, Hu B, Zhou ZQ, Guan J, Zhang ZY, Zhou GW. Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies [serial online]. World J Surg Oncol. 2015;13:161.
30. Palmer WC, Patel T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol. 2012;57:69-76.
31. Zhou Y, Zhao Y, Li B, et al. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis [serial online]. BMC Cancer. 2012;12:289.
32. Fillipowicz EA, Xiao S, Sower LE, Weems J, Payne DA. Detection of HCV in bile duct epithelium by laser capture microdissection (LCM). In Vivo. 2005;19:737-739.
33. Perumal V, Wang J, Thuluvath P, Choti M, Torbenson M. Hepatitis C and hepatitis B nucleic acids are present in intrahepatic cholangiocarcinomas from the United States. Hum Pathol. 2006;37:1211-1216.
34. Chen RF, Li ZH, Zou SQ, Chen JS. Effect of hepatitis C virus core protein on modulation of cellular proliferation and apoptosis in hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int. 2005;4:71-74.
35. Xu JH, Fu JJ, Wang XL, Zhu JY, Ye XH, Chen SD. Hepatitis B or C viral infection and risk of pancreatic cancer: a meta-analysis of observational studies. World J Gastroenterol. 2013;19:4234-4241.
36. Richardson D, Fisher M, Sabin CA. Sexual transmission of hepatitis C in MSM may not be confined to those with HIV infection. J Infect Dis. 2008;197:1213-1214, author reply 1214-1215.
37. Goldstone S, Palefsky JM, Giuliano AR, et al. Prevalence of and risk factors for human papillomavirus (HPV) infection among HIV-seronegative men who have sex with men. J Infect Dis. 2011;203:66-74.
38. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009;101:1120-1130.
39. Lanoy E, Dores GM, Madeleine MM, Toro JR, Fraumeni JF Jr, Engels EA. Epidemiology of nonkeratinocytic skin cancers among persons with AIDS in the United States. AIDS. 2009;23:385-393.
40. Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet Gynecol. 2007;110:1091-1095.
41. Reich H, DeCaprio J, McGlynn F. Laparoscopic hysterectomy. J Gynecol Surg. 1989;5:213-216.
42. Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009;101:374-383.
43. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst. 2001;93:705-709.
44. Montella M, Pezzullo L, Crispo A, et al. Risk of thyroid cancer and high prevalence of hepatitis C virus. Oncol Rep. 2003;10:133-136.
45. Yang JD, Mohammed HA, Cvinar JL, Gores GJ, Roberts LR, Kim WR. Diabetes mellitus heightens the risk of hepatocellular carcinoma except in patients with hepatitis C cirrhosis. Am J Gastroenterol. 2016;111:1573-1580.
46. Denniston MM, Klevens RM, McQuillan GM, Jiles RB. Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008. Hepatology. 2012;55:1652-1661.
47. Sayiner M, Wymer M, Golabi P, Ford J, Srishord I, Younossi ZM. Presence of hepatitis C (HCV) infection in baby boomers with Medicare is independently associated with mortality and resource utilisation. Aliment Pharmacol Ther. 2016;43:1060-1068.
48. Galbraith JW, Donnelly JP, Franco RA, Overton ET, Rodgers JB, Wang HE. National estimates of healthcare utilization by individuals with hepatitis C virus infection in the United States. Clin Infect Dis. 2014;59:755-764.
49. El-Serag HB, Kanwal F, Richardson P, Kramer J. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology. 2016;64:130-137.